In this retrospective cohort study, tirzepatide dispensations were found to have increased significantly following approval ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper ...

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...

The annual meeting of the American College of Physicians (Internal Medicine Meeting) was held from April 3 to 5 in New ...

New research shows that people who take the weight-loss drug tirzepatide can keep most of the weight off for at least three ...

Guggenheim lowered the firm’s price target on Eli Lilly (LLY) to $928 from $973 and keeps a Buy rating on the shares. The firm is updating its ...

Meghan Trainor's use of the hotly-debated diabetes drug Mounjaro to shed a few pounds has subsequently become somewhat of a ...

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

Taking tirzepatide drug once a week may produce clinically meaningful and sustained weight loss for at least 3 years in ...